Levofloxacin Injection in 5% Dextrose Shortage

• • Levofloxacin in 5% Dextrose intravenous solution for injection, Baxter, 250 mg/50 mL, flexible container, 24 count, NDC 36000-0046-24 - discontinued
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Baxter, 500 mg/100 mL, flexible container, 24 count, NDC 36000-0047-24 - discontinued
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Baxter, 750 mg/150 mL, flexible container, 24 count, NDC 36000-0048-24 - discontinued
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Hikma, 250 mg/50 mL, flexible container, 24 count, NDC 00143-9722-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Hikma, 500 mg/100 mL, flexible container, 24 count, NDC 00143-9721-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Hikma, 750 mg/150 mL, flexible container, 24 count, NDC 00143-9720-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Pfizer, 250 mg/50 mL, flexible container, 24 count, NDC 00409-2220-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Pfizer, 500 mg/100 mL, flexible container, 24 count, NDC 00409-3330-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Pfizer, 750 mg/150 mL, flexible container, 24 count, NDC 00409-4444-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Sagent, 250 mg/50 mL, flexible container, 24 count, NDC 25021-0132-81
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Sagent, 500 mg/100 mL, flexible container, 24 count, NDC 25021-0132-82
  • Levofloxacin in 5% Dextrose intravenous solution for injection, Sagent, 750 mg/150 mL, flexible container, 24 count, NDC 25021-0132-83
  • Levofloxacin in 5% Dextrose intravenous solution for injection, WG Critical Care, 750 mg/150 mL, flexible container, 24 count, NDC 44567-0437-24

• • Baxter has discontinued levofloxacin premixed bags.
  • Hikma did not provide a reason for the shortage.
  • Pfizer states the shortage is due to a manufacturing delay.
  • Sagent did not provide a reason for the shortage.
  • WG Critical Care did not provide a reason for the shortage.

• • Levofloxacin in 5% Dextrose intravenous solution for injection, WG Critical Care, 250 mg/50 mL, flexible container, 24 count, NDC 44567-0435-24
  • Levofloxacin in 5% Dextrose intravenous solution for injection, WG Critical Care, 500 mg/100 mL, flexible container, 24 count, NDC 44567-0436-24

Estimated Resupply Dates

• • Hikma has levofloxacin 250 mg/50 mL, 500 mg/100 mL, and 750 mg/150 mL premixed bags on back order and the company estimates a release date of early-August 2025 for the 250 mg bags, mid-August 2025 for the 500 mg bags, and early-April 2025 for the 750 mg bags.
  • Pfizer has levofloxacin 500 mg/100 mL premixed bags and 750 mg/150 mL premixed bags available in limited supply. The 250 mg/50 mL premixed bags are on back order and the company estimates a release date of June 2025.
  • Sagent has levofloxacin 250 mg/50 mL, 500 mg/100 mL, and 750 mg/150 mL premixed bags on back order and the company estimates a release date of April 2025 for the 250 mg and 500 mg bags and July 2025 for the 750 mg bags.
  • WG Critical Care has levofloxacin 750 mg/150 mL premixed bags on back order and the company estimates a release date of May 2025.